AMED to Allocate 240 Million Yen for R&D of Innovative Cancer Treatments, Including CAR-T Cell Therapy

The Japan Agency for Medical Research and Development (AMED) and the Cabinet Secretariat’s office for health and medical strategies announced on November 21 plans to allocate AMED’s coordination fund for R&D in the field of healthcare. Among other things, the...read more